Risks related to defective products, medical accidents and product recalls
First written in FY2016. 24 of 26 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2026: 12 of 60 companies on the "Worse" side.
- FY2025RestatedAnnual report
「The Group conducts thorough quality control and has established a quality assurance system based on the ISO international standards for quality management systems. In addition, the Group covers medical accidents that cannot be completely ruled out despite these measures through the necessary insurance.」
The possibility of defective products, medical accidents, litigation and recalls is identified as a remaining risk, while ISO-based quality control and insurance coverage continue to be described as the response. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2022RestatedAnnual report
「However, the possibility that defective products may arise during the manufacture or transportation of products, or that products may be handled improperly in medical settings, cannot be completely ruled out. If a medical accident or other incident occurs, it could develop into litigation under product liability. …The Group conducts thorough quality control and has established a quality assurance system based on the ISO international standards for quality management systems. In addition, the Group covers medical accidents that cannot be completely ruled out despite these measures through the necessary insurance.」
The possibility of defective products, medical accidents, litigation and recalls is identified as a remaining risk, while ISO-based quality control and insurance coverage continue to be described as the response. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2021MitigatedAnnual report
「The Group conducts thorough quality control and has established a quality assurance system based on the ISO international standards for quality management systems. In addition, the Group covers medical accidents that cannot be completely ruled out despite these measures through the necessary insurance.」
While stating that risks of defective products, medical accidents and recalls remain, the description specifies the response through ISO-based quality control and necessary insurance. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2018RestatedAnnual report
「However, the possibility that defective products may arise during the manufacture or transportation of products, or that products may be handled improperly in medical settings, cannot be completely ruled out. If a medical accident or other incident occurs, it could develop into litigation under product liability. In addition, the Group may become responsible for recalling related products under the laws and regulations of the countries where the products are sold.」
The possibility of defective products, medical accidents, litigation and product recalls continues to be described as before. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2017-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of defective products, medical accidents and product recalls have been reconfirmed through a comprehensive statement that there have been no material changes. - FY2016First statedAnnual report
「The possibility that defective products may arise during the manufacture or transportation of products, or that products may be handled improperly in medical settings, cannot be completely ruled out. If a medical accident or other incident occurs, it could develop into litigation under product liability. In addition, the Group may become responsible for recalling related products under the laws and regulations of the countries where the products are sold.」
While maintaining a quality control system, the description addresses the possibility of defective products, improper handling, medical accidents, litigation and product recall liability.